NEW YORK (GenomeWeb) – High-sensitivity immunoassay firm Quanterix announced on its Q4 earnings call this week that it has acquired microarray company Aushon BioSystems.

Kevin Hrusovsky, Quanterix's executive chairman and CEO, said during the call that in the near term the deal gives Quanterix access to Aushon's CLIA facility and allows it to bring aboard a number of Aushon employees it had hoped to hire this year.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb or 360Dx Premium member?
Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.